Fiercebiotech
Published November 17, 2026 · Updated November 18, 2026
Helus' chemically modified psychedelic hits key goals in phase 3 depression trial
Read the full story at Fiercebiotech
Helus Pharma major depressive disorder psilocybin phase 3 psychedelic drug Clinical Data Biotech . Marissa Russo. By Marissa Russo. Staff Writer.
Surfaced by this Google Alert
- Psychedelic biotech